glucagon antagonists (Ureka/CNRS)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameglucagon antagonists (Ureka/CNRS)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon receptor antagonists
TargetsGlucagon receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUreka Sarl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUreka SarlCentre National De La Recherche Scientifique (Cnrs)
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksN/A